Mirum Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for th…

Biotechnology
US, Foster City [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of MIRM's Analysis
CIK: 1759425 CUSIP: 604749101 ISIN: US6047491013 LEI: - UEI: -
Secondary Listings
MIRM has no secondary listings inside our databases.